Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people

Journal of the American Geriatrics Society

Volumn 63, Issue 1, 2015, Pages 85-90

  Salahudeen, Mohammed Saji ^a   Hilmer, Sarah N ^b,c   Nishtala, Prasad S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adverse outcome; Anticholinergic; Hospitalization; Older people; Risk scale

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ATENOLOL; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CODEINE; DIGOXIN; DILTIAZEM; DIPYRIDAMOLE; FLUOXETINE; FUROSEMIDE; IMIPRAMINE; ISOSORBIDE; LEVOMEPROMAZINE; LOPERAMIDE; LORATADINE; METOCLOPRAMIDE; METOPROLOL; NORTRIPTYLINE; ORPHENADRINE; OXYBUTYNIN; PAROXETINE; PREDNISONE; PROCHLORPERAZINE; QUETIAPINE; RANITIDINE; THEOPHYLLINE; TRAMADOL; UNINDEXED DRUG;

AGED; AGING; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DRUG BURDEN INDEX ANTICHOLINERGIC COMPONENT; DRUG EXPOSURE; DRUG SAFETY; ETHNICITY; FALLING; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ICD-10; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEW ZEALAND; OUTCOME ASSESSMENT; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; POPULATION BASED CASE CONTROL STUDY; PREDICTOR VARIABLE; PREVALENCE; RATING SCALE; RISK ASSESSMENT; SCORING SYSTEM; COMPARATIVE STUDY; FEMALE; MALE; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; FEMALE; GENERAL PRACTITIONERS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; NEW ZEALAND; RISK ASSESSMENT;

EID: 84925281323     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13206     Document Type: Article

References (58)

1. De Wilde S, Carey IM, Harris T et al. Trends in potentially inappropriate prescribing amongst older UK primary care patients. Pharmacoepidemiol Drug Saf 2007;16:658-667.
2. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993;3: 335-348.
3. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989;321:303-309.
4. Tune L, Carr S, Hoag E et al. Anticholinergic effects of drugs commonly prescribed for the elderly: Potential means for assessing risk of delirium. Am J Psychiatry 1992;149:1393-1394.
5. Chew ML, Mulsant BH, Pollock BG et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008;56:1333-1341.
6. Ancelin ML, Artero S, Portet F et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. BMJ 2006;332:455-459.
7. Boustani M, Campbell N, Munger S et al. Impact of anticholinergics on the aging brain: A review and practical application. Aging Health 2008;4:311-320.
8. Carnahan RM, Lund BC, Perry PJ et al. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity. J Clin Pharmacol 2006;46:1481-1486.
9. Ehrt U, Broich K, Larsen JP et al. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: A cohort study. J Neurol Neurosurg Psychiatry 2010;81:160-165.
10. Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc 2008;56:2203-2210.
11. Rudolph JL, Salow MJ, Angelini MC et al. The Anticholinergic Risk Scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008;168:508-513.
12. Sittironnarit G, Ames D, Bush AI et al. Effects of anticholinergic drugs on cognitive function in older Australians: Results from the AIBL study. Dement Geriatr Cogn Disord 2011;31:173-178.
13. Tune LE, Damlouji NF, Holland A et al. Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 1981;2:651-653.
14. Mulsant BH, Pollock BG, Kirshner M et al. Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance. Arch Gen Psychiatry 2003;60:198-203.
15. Thomas C, Hestermann U, Kopitz J et al. Serum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without delirium. BMC Neurosci 2008;9:86.
16. Tollefson GD, Montague-Clouse J, Lancaster SP. The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci 1991;3:314-319.
17. Nishtala PS, Fois RA, McLachlan AJ et al. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. J Clin Pharmacol 2009;49: 1176-1184.
18. Cox EA, Kwatra SG, Shetty S et al. Flaws in the serum anticholinergic activity assay: Implications for the study of delirium. J Am Geriatr Soc 2009;57:1707-1708.
19. Hilmer SN, Mager DE, Simonsick EM et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007;167:781-787.
20. Boustani M, Baker MS, Campbell N et al. Impact and recognition of cognitive impairment among hospitalized elders. J Hosp Med 2010;5:69-75.
21. Kersten H, Wyller TB. Anticholinergic drug burden in older people's brain - how well is it measured? Basic Clin Pharmacol Toxicol 2014;114:151-159.
22. Kersten H, Molden E, Willumsen T et al. Higher Anticholinergic Drug Scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. Br J Clin Pharmacol 2013;75:842-849.
23. Pasina L, Djade CD, Lucca U et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale: Results from the REPOSI study. Drugs Aging 2013;30:103-112.
24. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000;93: 457-462.
25. Koyama A, Steinman M, Ensrud K et al. Long-term cognitive and functional effects of potentially inappropriate medications in older women. J Gerontol A Biol Sci Med Sci 2014;69A:423-429.
26. Fox C, Richardson K, Maidment ID et al. Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study. J Am Geriatr Soc 2011;59:1477-1483.
27. West T, Pruchnicki MC, Porter K et al. Evaluation of anticholinergic burden of medications in older adults. J Am Pharm Assoc (2003) 2013;53:496- 504.
28. Narayan SW, Hilmer SN, Horsburgh S et al. Anticholinergic component of the Drug Burden Index and the Anticholinergic Drug Scale as measures of anticholinergic exposure in older people in New Zealand: A populationlevel study. Drugs Aging 2013;30:927-934.
29. Gnjidic D, Cumming RG, Le Couteur DG et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009;68:97-105.
30. Wilson NM, Hilmer SN, March LM et al. Associations between Drug Burden Index and falls in older people in residential aged care. J Am Geriatr Soc 2011;59:875-880.
31. Clark DO, Von Korff M, Saunders K et al. A chronic disease score with empirically derived weights. Med Care 1995;33:783-795.
32. Gnjidic D, Hilmer SN, Hartikainen S et al. Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer's disease: A national population cohort study. PLoS ONE 2014;9: e83224.
33. Lonnroos E, Gnjidic D, Hilmer SN et al. Drug Burden Index and hospitalization among community-dwelling older people. Drugs Aging 2012;29:395-404.
34. Lowry E, Woodman RJ, Soiza RL et al. Associations between the Anticholinergic Risk Scale score and physical function: Potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc 2011;12:565-572.
35. Uusvaara J, Pitkala K, Kautiainen H et al. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients. Drugs Aging 2011;28:131-138.
36. Cao YJ, Mager DE, Simonsick EM et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008;83:422-429.
37. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001;62(Suppl 21):11-14.
38. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15-28.
39. Nishtala PS, Narayan SW, Wang T et al. Associations of Drug Burden Index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf 2014;23:753-758.
40. Kashyap M, Belleville S, Mulsant BH et al. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc 2014;62: 336-341.
41. Low LF, Anstey KJ, Sachdev P. Use of medications with anticholinergic properties and cognitive function in a young-old community sample. Int J Geriatr Psychiatry 2009;24:578-584.
42. Kersten H, Molden E, Tolo IK et al. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: A randomized controlled trial. J Gerontol A Biol Sci Med Sci 2013;68A:271-278.
43. Lampela P, Lavikainen P, Garcia-Horsman JA et al. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: A population-based study. Drugs Aging 2013;30:321-330.
44. Agar M, Currow D, Plummer J et al. Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches. Palliat Med 2009;23:257-265.
45. Juliebo V, Bjoro K, Krogseth M et al. Risk factors for preoperative and postoperative delirium in elderly patients with hip fracture. J Am Geriatr Soc 2009;57:1354-1361.
46. Yeh Y-C, Liu C-L, Peng L-N et al. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: A prospective cohort study. Geriatr Gerontol Int 2013;13:694-700.
47. Kumpula EK, Bell JS, Soini H et al. Anticholinergic drug use and mortality among residents of long-term care facilities: A prospective cohort study. J Clin Pharmacol 2011;51:256-263.
48. Lowry E, Woodman RJ, Soiza RL et al. Clinical and demographic factors associated with antimuscarinic medication use in older hospitalized patients. Hosp Pract 2011;39: 30-36.
49. Koshoedo S, Soiza RL, Purkayastha R et al. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation. Am J Geriatr Pharmacother 2012;10:251-257.
50. Kolanowski A, Fick DM, Campbell J et al. A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia. J Am Med Dir Assoc 2009;10:252-257.
51. Campbell NL, Boustani MA, Lane KA et al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 2010;75:152-159.
52. Campbell N, Perkins A, Hui S et al. Association between prescribing of anticholinergic medications and incident delirium: A cohort study. J Am Geriatr Soc 2011;59(Suppl 2):S277-S281.
53. Fox C, Livingston G, Maidment ID et al. The impact of anticholinergic burden in Alzheimer's dementia - the LASER-AD study. Age Ageing 2011;40:730-735.
54. Cai X, Campbell N, Khan B et al. Long-term anticholinergic use and the aging brain. Alzheimers Dement 2013;9: 377-385.
55. Koyama A, Steinman M, Ensrud K et al. Ten-year trajectory of potentially inappropriate medications in very old women: Importance of cognitive status. J Am Geriatr Soc 2013;61:258-263.
56. Shah RC, Janos AL, Kline JE et al. Cognitive decline in older persons initiating anticholinergic medications. PLoS ONE 2013;8:e64111.
57. L Lanctôt K, O'Regan J, Schwartz Y et al. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease. Psychosomatics 2014;55:61-68.
58. Mangoni AA, van Munster BC, Woodman RJ et al. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry 2013;21:785-793.